Biz Roadmap ('26~'28)

Medical
H2V MD
Early Detection of HF Worsening in Post-Discharge Patients
→
U.S. Entry
Non-Medical
Voice Care
Health Risk Monitoring for High-Risk Individuals
'26~'27 Korea
'27~'28 U.S.

Track 1 — Medical

H2V MD · Early Detection of HF Worsening in Post-Discharge Patients '26~'28
HF Post-Discharge
Prescription
→
Daily Voice
Monitoring
→
Early Detection
of Worsening
→
Early Intervention
(Outpatient)
Approval
  • Confirmatory clinical trial with MFDS (8 sites, ~150 patients) from H2 2026
  • Market entry via innovative medical device integrated review (Q1 2027)
Distribution
  • Partnership with pharma & diagnostics companies (~Q3 2026)
U.S.
  • RPM based Digital Medical Device for U.S. Market Entry ('27~'28)

Track 2 — Non-Medical

Voice Care · Health Risk Monitoring for High-Risk Individuals '26~'27
Health Screening Centers Insurers Smartphone + Watch
Target
  • High-risk HF individuals: chronic conditions (hypertension, obesity) & cardiovascular patients
  • Domestic ~14M / Global ~1.8B
Service
  • Weekly voice check (1~2x/week) for continuous health risk monitoring
  • Risk-triggered referral to counseling, care, screening & clinic
Revenue
  • Monthly subscription: ~USD 15/user (B2C basis)
PoC
  • Domain-specific PoC planned for H2 2026